Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110145 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von N P Syamprasad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila village, Changsari, Assam 781101,…. Hauptthemen laut MEDLINE: Colitis, Colitis, Ulcerative, Colonic Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Israel Atomic Energy Commission, National Institute of Pharmaceutical Education and Research, Raebareli.
Abstract (Originalsprache)
Identifying the target linking inflammation and oxidative stress to aggravate the disease progression will help to prevent colitis associated carcinogenesis. Since AKR1B1 overexpression is observed in inflammatory diseases and various cancers, we have investigated the role of AKR1B1 in colitis-associated colon carcinogenesis with the aid of epalrestat and its potent analogue NARI-29 (investigational molecule) as pharmacological probes. A TNF-α inducible NF-κB reporter cell line (GloResponse™ NF-κB-RE-luc2P HEK293) and dextran sodium sulfate (DSS) and 1,2 dimethyl hydrazine (DMH))-induced mouse model was used to investigate our hypothesis in vitro and in vivo. Clinically, an increased expression of AKR1B1 was observed in patients with ulcerative colitis. Our in vitro and in vivo findings suggest that the AKR1B1 modulated inflammation and ROS generation for the progression of colitis to colon cancer. AKR1B1 overexpression was observed in DSS + DMH-treated mice colons. Moreover, we could observe histopathological changes like immune cell infiltration, aberrant crypt foci, and tumour formation in DC groups. Mechanistically, we have witnessed modulation of the IKK/IκB/NF-κB and Akt/FOXO-3a/DR axis, increased inflammatory cytokines, increased expression of proliferative markers, Ki-67 and PCNA, and accumulation of β-catenin in the colon epithelium. However, pharmacological inhibition of AKR1B1 using NARI-29 or EPS has reversed the clinical, histopathological, and molecular alterations induced by DSS + DMH, confirming the obvious role of AKR1B1 in the promotion of colitis-associated carcinogenesis. In conclusion, our findings suggest that AKR1B1 targeted therapy could be a promising strategy for preventing CA-CRC and NARI-29 could be developed as a potent AKR1B1 inhibitor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila village, Changsari, Assam 781101, India.
- Advance Centre for Treatment Research & Education in Cancer, Tata Memorial Centre, (ACTREC), Plot No. 1 & 2, Sector 22, Kharghar, Navi Mumbai, Maharashtra 410210, India.
- Fluoro Agro Chemicals Department and AcSIR-Ghaziabad, CSIR-Indian Institute of Chemical Technology, Uppal Road Tarnaka, Hyderabad, Telangana 500007, India.
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila village, Changsari, Assam 781101, India. Electronic address: jagadeesh@niperguwahati.in.
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila village, Changsari, Assam 781101, India. Electronic address: vgmnaidu@niperguwahati.ac.in.
Förderung
- Israel Atomic Energy Commission
- National Institute of Pharmaceutical Education and Research, Raebareli
Zitieren
APA
Syamprasad, N. P., Rajdev, B., Jain, S., Panda, S. R., Puppala, E. R., Chaudhari, P., Vaidya, J. R., Kumar, G. J., & Naidu, V. G. M. (2023). Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110145
Vancouver
Syamprasad NP, Rajdev B, Jain S, Panda SR, Puppala ER, Chaudhari P, et al. Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110145
BibTeX
@article{Syamprasad2023,
author = {Syamprasad, N P and Rajdev, Bishal and Jain, Siddhi and Panda, Samir Ranjan and Puppala, Eswara Rao and Chaudhari, Pradip and Vaidya, Jayathirtha Rao and Kumar, Gangasani Jagadeesh and Naidu, V G M},
title = {Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110145}
}
EUVIMED